Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR52N4 Inhibitors

OR52N4 inhibitors are a specific class of chemical compounds that target the OR52N4 receptor, a member of the olfactory receptor family, which belongs to the larger G-protein-coupled receptor (GPCR) superfamily. Olfactory receptors like OR52N4 are primarily recognized for their role in detecting odorants in the nasal epithelium, but they are also expressed in a variety of other tissues, suggesting potential roles beyond olfaction. The function of OR52N4 in these non-olfactory tissues remains an area of active research. Inhibitors of OR52N4 are designed to interfere with the normal activity of this receptor, potentially modulating the physiological processes in which OR52N4 is involved. These inhibitors work by binding to the receptor in a manner that blocks or diminishes its ability to interact with its natural ligands, thereby altering the receptor's signaling pathways. The chemical nature of OR52N4 inhibitors can vary widely, encompassing different structural classes and mechanisms of action. These compounds might bind directly to the receptor's ligand-binding domain, effectively competing with endogenous ligands, or they could bind allosterically, inducing conformational changes that impair receptor function. The development of these inhibitors typically involves detailed structural analysis of OR52N4, often using techniques such as X-ray crystallography, nuclear magnetic resonance (NMR), and computational modeling to identify key binding sites and design molecules that can selectively target the receptor. The study of OR52N4 inhibitors is crucial for understanding the broader biological roles of this receptor and how its inhibition can influence various cellular processes. Researchers focus on optimizing the potency, specificity, and selectivity of these inhibitors to ensure they effectively modulate OR52N4 activity without affecting other receptors or proteins, which is essential for elucidating the precise functions of OR52N4 in different biological systems.

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

Flavopiridol inhibits cyclin-dependent kinases, which may be necessary for the transcription of certain genes. This could result in the suppression of OR52N4 transcription if the gene is dependent on these kinases for expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

This histone deacetylase inhibitor could lead to an accumulation of acetylated histones at the OR52N4 gene locus, potentially causing a downregulation of its expression if such modification creates a repressive chromatin state.